Combining radiation and molecular targeting in cancer therapy.
about
Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.Biological response of cancer cells to radiation treatment.Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer.1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice.Novel interaction of the Hsp90 chaperone machine with Ssl2, an essential DNA helicase in Saccharomyces cerevisiae.Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment.Inhibiting kinases in malignant gliomas.Cancer cell signaling pathways targeted by spice-derived nutraceuticals.A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cellsTargeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha.PPARγ regulated CIDEA affects pro-apoptotic responses in glioblastoma.Combination therapy for malignant glioma based on PTEN status.The role of apoptosis in radiation oncology.Targeting of tumor endothelial cells combining 2 Gy/day of X-ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors.Medical therapies for meningiomas.Targeting NR4A1 (TR3) in cancer cells and tumorsThe promise of mTOR inhibitors in the treatment of colorectal cancer.The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrenceUCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization.Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity.Thymoquinone restores radiation-induced TGF-β expression and abrogates EMT in chemoradiotherapy of breast cancer cells.EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.The determination of the absolute configuration of a chiral 2,3'-diindolylarylmethane by NMR spectroscopy.Sensitization of ionizing radiation-induced apoptosis by ursolic acid.Overexpression of PPARγ can down-regulate Skp2 expression in MDA-MB-231 breast tumor cells.PPARgamma and Wnt/beta-Catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical/prognostic correlations.Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy.Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1.Activation of Nur77 by selected 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways.Why "radiation oncology".Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid.Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer.The Disubstitution of Acetals to Prepare δ,δ-Bis(aryl) β-Keto Esters
P2860
Q34741141-D9DF88AD-4E42-4A1A-995F-CA6428894D5BQ35600132-59ABAC0D-D193-462D-BB41-6F02EF3B23B4Q36187022-4BCFA19F-6491-4C82-A482-D79CCD78A5D6Q36393316-2966222E-D74E-49CD-83B4-8DE325FB9AA6Q36496582-AF2B6AAD-BB7F-42D3-9E83-132EC068FE20Q36499234-FFA9670B-B9BB-4497-9B3F-2501A5BF6EFDQ36764876-20F1FB07-3365-4FA1-94C9-184B195C32A8Q36819371-1E764BF1-A240-4EFD-96FC-CC2CAAA8B6C4Q36897684-808DA870-0A5D-42CB-861F-E65A288261F0Q37106192-42E0E855-C047-49B8-A093-6CB02BA27436Q37164423-3C059651-2425-4EDB-BEE2-C65DEEB2D334Q37316986-E5793E7B-02BD-491D-9543-900CB195390BQ37413111-F334BC2F-5078-4F1F-A9E6-B5D7AD347873Q37703384-11E71F9A-48C3-459F-8CCA-2C5A1A5D947DQ37785808-96112A9E-D381-41E6-BEF9-6ED7138EEFADQ37825901-55AE2A14-3A13-4AEE-8846-40DED773D136Q38043507-FD52D12E-71F8-4F4E-9131-2189D023F292Q38536374-EE7B8542-9C5F-4685-8021-7238D5B53DE2Q38696038-B5E3CE7F-A363-425D-822D-B3DAC30AFC4DQ38921461-73E6359E-B8AA-43D2-B25C-A9E51ECA4E1DQ38962304-C3A1C0B0-42C6-4D07-9D96-5DFE1C309AAEQ38990966-2D1F8D87-5FF7-4E25-A382-5F294E9C09FBQ39051600-289A6F49-FDE3-4C4D-8604-4766390F4FC6Q39413290-52CBB673-F6E3-478D-9569-0C05DD2EC9A6Q39664073-1F340DB1-ED2E-41E4-91DA-4CB1707B8E43Q39973758-D123D02E-3DA2-4A37-85BA-EDD03B57F6E2Q40023155-F2792324-D15C-49E5-909D-D2A414F8EF9EQ40165950-24700A92-91DC-4BE0-B73F-2F968A4221F7Q40419035-B75F8625-4000-4C4D-B1E4-D3594B450532Q40426627-BFB591C2-6C6B-47EA-AE17-EB052ADE5625Q43159760-51A8EFBF-AF3E-4880-9FDB-3C2F161CEF6FQ45172727-20294927-57C3-498A-A125-F423AA5281B4Q50437809-5741C3A4-76D5-47DC-BD94-D3F91D72A78CQ57404788-01BBDCA9-A864-458D-9FF2-F08BC252BC79
P2860
Combining radiation and molecular targeting in cancer therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Combining radiation and molecular targeting in cancer therapy.
@ast
Combining radiation and molecular targeting in cancer therapy.
@en
type
label
Combining radiation and molecular targeting in cancer therapy.
@ast
Combining radiation and molecular targeting in cancer therapy.
@en
prefLabel
Combining radiation and molecular targeting in cancer therapy.
@ast
Combining radiation and molecular targeting in cancer therapy.
@en
P356
P1476
Combining radiation and molecular targeting in cancer therapy.
@en
P2093
Kevin Camphausen
Philip J Tofilon
P304
P356
10.4161/CBT.3.3.544
P577
2004-03-16T00:00:00Z